About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

A Phase 2a Trial to Evaluate the Safety, Tolerability, and Efficacy of 12 Weeks of Sovaprevir, ACH-0143102 and Ribavirin in Treatment-Naive Subjects With Chronic Hepatitis C Genotype-1 Viral Infection

NCT01849562•Alexion Pharmaceuticals, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Hepatitis C, Chronic

Interventions

Sovaprevir

ACH-3102

+2 more

Key Dates

Start Date

April 1, 2013

Primary Completion Date

November 1, 2013

Completion Date

April 1, 2014

Last Updated

August 29, 2023

Related Studies

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

NCT05870969

Carcinoma, HepatocellularHepatitis C, Chronic+3 more

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

NCT03200379

Hepatitis C, Chronic

Integrated Treatment of Hepatitis C Virus Infection

NCT03155906

Hepatitis C, ChronicOpioid Dependence, on Agonist Therapy

COMPLETEDPhase 4

The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

NCT03987503

Hepatitis C, Chronic

Linkage to Care for Persons with Hep C Infection

NCT05397067

Hepatitis C, ChronicSubstance Use Disorders

COMPLETEDPhase 1

Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir

NCT04382404

Hepatitis C, Chronic

View all related studies

Sponsors

Lead Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

Achillion, a wholly owned subsidiary of Alexion

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions